Diagnosis and classification of cancer using hybrid model based on ReliefF and convolutional neural network.
Clicks: 349
ID: 87243
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
80.6
/100
349 views
239 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #14 of 72 articles by views in medical hypotheses
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Machine learning and deep learning methods aims to discover patterns out of datasets such as, microarray data and medical data. In recent years, the importance of producing microarray data from tissue and cell samples and analyzing these microarray data has increased. Machine learning and deep learning methods have been started to use in the diagnosis and classification of microarray data of cancer diseases. However, it is challenging to analyze microarray data due to the small number of sample size and high number of features of microarray data and in some cases some features may not be relevant with the classification. Because of this reason, studies in the literature focused on developing feature selection/dimension reduction techniques and classification algorithms to improve classification accuracy of the microarray data. This study proposes hybrid methods by using Relief and stacked autoencoder approaches for dimension reduction and support vector machines (SVM) and convolutional neural networks (CNN) for classification. In the study, three microarray datasets of Overian, Leukemia and Central Nervous System (CNS) were used. Ovarian dataset contains 253 samples, 15,154 genes and 2 classes, Leukemia dataset contains 72 samples, 7129 genes, and 2 classes and CNS dataset contains 60 samples, 7129 genes and 2 classes. Among the methods applied to the three microarray data, the best classification accuracy without dimension reduction was observed with SVM as 96.14% for ovarian dataset, 94.83% for leukemia dataset and 65% for CNS dataset. The proposed hybrid method ReliefF + CNN method outperformed other approaches. It gave 98.6%, 99.86% and 83.95% classification accuracy for the datasets of ovarian, leukemia, and CNS datasets, respectively. Results shows that dimension reduction methods improved the classification accuracy of the methods of SVM and CNN.
| Reference Key |
kilicarslan2020diagnosismedical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Kilicarslan, Serhat;Adem, Kemal;Celik, Mete; |
| Journal | medical hypotheses |
| Year | 2020 |
| DOI |
S0306-9877(19)31363-5
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.